The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

EDCTP Prizes 2018

Call for Nominations: EDCTP Prizes 2018

Deadline Friday, 06 April 2018

Read more

Stakeholder meeting

Co-infections and co-morbidities – report of the 2017 meeting on priorities.

Latest news

23 March 2018

World TB Day: EDCTP commits EUR 34M to TB vaccine clinical trials

True to the World Tuberculosis Day 2018 theme ‘Wanted: Leaders for a TB-free world’, the European Union and European member…

Read more
22 March 2018

TB treatment consortium PanACEA2 held second annual meeting

The EDCTP-funded PanACEA2 consortium held its second annual meeting in Cape Town, South Africa from 28 February to 1 March…

Read more